PLK4 and glioblastoma: Our results showed lower enrichment scores for multiple metagenes such as LCK, MHC-II and STAT1 in GBM patients with higher PLK4 expression levels from the TCGA, CGGA_693, and CGGA_325 datasets (Supplementary Figure 9).